HF
SRDX

HRT Financial’s Surmodics SRDX Stock Holding History

HRT Financial’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-48,873
Closed -$1.46M – 4000
2025
Q3 		$1.46M Buy
48,873
+33,111
+210% +$1.11M 0.01% 1326
2025
Q2 		$468K Sell
15,762
-85,723
-84% -$2.47M ﹤0.01% 1639
2025
Q1 		$3.1M Buy
+101,485
New +$3.42M 0.02% 623
2024
Q2 		– Sell
-28,821
Closed -$845K – 3051
2024
Q1 		$845K Sell
28,821
-1,829
-6% -$58.3K 0.01% 964
2023
Q4 		$1.11M Sell
30,650
-3,630
-11% -$119K 0.01% 933
2023
Q3 		$1.1M Buy
34,280
+3,153
+10% +$107K 0.01% 915
2023
Q2 		$974K Sell
31,127
-17,776
-36% -$406K 0.01% 967
2023
Q1 		$1.11M Buy
+48,903
New +$1.26M 0.01% 892
2021
Q4 		– Sell
-6,655
Closed -$370K – 4035
2021
Q3 		$370K Buy
6,655
+2,834
+74% +$157K ﹤0.01% 2265
2021
Q2 		$207K Buy
+3,821
New +$210K ﹤0.01% 2368

Other funds holding SRDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HRT Financial's SRDX Position: Q4 2025 in Review

HRT Financial sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 48,873 shares — an estimated $1.46M sold.

HRT Financial first reported a position in SRDX in Q2 2021 and held it in 10 quarters. The position peaked at $3.1M in Q1 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • HRT Financial reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 48,873 Surmodics shares in Q4 2025, an estimated $1.46M.
  • HRT Financial first reported a position in Surmodics in Q2 2021 and held it in 10 quarters.
  • HRT Financial's Surmodics position peaked at $3.1M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.